| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |